Quick Facts
- Sample: Venous blood draw
- Fasting: No fasting required
- Turn-around: 2-3 business days. May take longer based on weather, holiday, or lab delays.
Benefits
- Early protection - Identifies hepatitis B to prevent vertical transmission affecting 24,000 annual births
- Rh compatibility - Determines Rh factor to prevent hemolytic disease in future pregnancies
- Immunity assessment - Confirms rubella protection against serious fetal defects
- No referral needed - Direct ordering eliminates appointment delays and insurance approvals
- Comprehensive screening - Essential first-trimester tests recommended by ACOG guidelines
- Convenient access - Available at 2,300+ lab locations nationwide
Who Is This Test For?
- All pregnant women in their first trimester (weeks 6-12)
- Women planning pregnancy who want baseline health assessment
- Those seeking privacy in their prenatal healthcare decisions
- Remote area residents with limited healthcare access
- Anyone wanting direct-to-consumer testing without physician referrals
- Health-conscious individuals prioritizing early detection and prevention
How It Works – Just 3 Steps
- Order Online - Purchase your test directly through our secure platform without physician referral
- Visit Lab - Get your blood drawn at any of our 2,300+ convenient locations nationwide
- Get Results - Access your results securely online within 2-3 business days.
FAQ
When is the best time to take this test? Ideally during weeks 6-10 of pregnancy at your first prenatal visit, though testing remains beneficial throughout the first trimester.
Do I need to fast before this blood test? No fasting is required for this panel—you can eat and drink normally before your blood draw.
What happens if I test positive for hepatitis B? Positive results require immediate medical consultation and specialist referral, plus planning for infant prophylaxis within 12 hours of birth.
Why is Rh factor testing important? Rh-negative mothers need RhoGAM treatment at 28 weeks and postpartum to prevent hemolytic disease in subsequent pregnancies.
Can I take this test if I'm not pregnant? While designed for pregnancy, this panel can provide valuable health information for any woman of childbearing age.
How accurate are these tests? Hepatitis B screening shows >98% sensitivity and specificity, while blood typing demonstrates >99% accuracy rates.
More Details
What is the purpose of this test?
The Morgan Prenatal Blood Test Panel #1 screens for hepatitis B infection, determines blood type and Rh status, and assesses rubella immunity to prevent maternal-fetal transmission and complications during pregnancy (ACOG 2024, CDC 2025). This comprehensive first-trimester screening evaluates critical biomarkers that significantly impact both maternal and fetal health outcomes.
Without proper screening, 70-90% of HBeAg-positive mothers transmit hepatitis B to their infants, with 90% of infected newborns developing chronic infection (Johns Hopkins 2024). Early detection enables timely interventions that can prevent serious complications and improve outcomes for both mother and baby.
Who would benefit from this test?
All pregnant women should receive this screening panel at their first prenatal visit, regardless of age, vaccination status, or risk factors, as recommended by ACOG and CDC guidelines (ACOG 2024, CDC 2025). This universal screening approach ensures comprehensive maternal health assessment and early identification of potential complications.
Women in remote areas, those seeking privacy in healthcare decisions, or anyone wanting direct-to-consumer testing without traditional barriers benefit significantly from this accessible screening option. The test is particularly valuable for health-conscious consumers who prioritize proactive healthcare management.
When should I order Morgan Prenatal Blood Test Panel #1?
Ideally during weeks 6-10 of pregnancy at the first prenatal visit, though testing can be beneficial throughout the first trimester (Vanderbilt Health 2024, Mayo Clinic 2024). Early testing allows for timely interventions and appropriate medical management throughout pregnancy.
Women receiving prenatal care starting at 9.3 weeks gestation show significantly reduced complications compared to later care initiation, emphasizing the importance of early screening (Clinical Studies 2024).
How do I interpret the results?
Hepatitis B Surface Antigen
- Normal Result: Negative
- Clinical Significance: No current infection; a positive result requires immediate medical consultation
ABO Blood Group
- Normal Result: A, B, AB, or O
- Clinical Significance: Determines blood type for transfusion compatibility
Rh Factor
- Normal Result: Positive or Negative
- Clinical Significance: Negative status requires RhoGAM treatment and monitoring
Rubella IgG Antibodies
- Normal Result: >10 IU/mL
- Clinical Significance: Indicates immunity; <10 IU/mL suggests susceptibility
Approximately 15% of Caucasians and 5-8% of African Americans are Rh-negative, requiring special monitoring during pregnancy (Cleveland Clinic 2024).
Disclaimer: Reference ranges may vary by laboratory. Listed ranges are general guidelines and may differ from those used by the performing lab. Always consult your healthcare provider for interpretation.
Pre-test preparation
No special preparation is required for this comprehensive screening panel. Continue all current medications as no adjustments are necessary for accurate results (Walk-In Lab 2024). Maintain normal hydration levels to facilitate blood draw and ensure optimal sample collection.
Schedule your test during optimal timing windows (weeks 6-12 of pregnancy) for maximum clinical benefit and early intervention opportunities.
How often should I get tested?
- First pregnancy: Once during first trimester
- Subsequent pregnancies: Each pregnancy (new screening required)
- Hepatitis B positive: Regular monitoring with specialist care
- Rh-negative status: Antibody monitoring throughout pregnancy
Why early detection matters
Early prenatal screening is crucial as it allows women to begin appropriate care as early as 6-9 weeks gestation, significantly reducing risks of complications such as gestational diabetes, preeclampsia, and preterm birth (RACGP 2024). The U.S. maternal mortality rate reached 19 deaths per 100,000 live births in 2024, emphasizing the critical importance of early prenatal screening (AP News 2024).
Universal screening prevents approximately 24,000 annual perinatal hepatitis B infections in the United States (CDC Prevention 2024). Early detection enables interventions that can dramatically improve outcomes for both mothers and infants.
Related tests you may consider
Morgan Prenatal Blood Test Panel #2- Checks for hepatitis B, HIV, syphilis, blood type, RH factor, and immunity to rubella to help protect both the mother and baby during pregnancy.
Maternal Serum AFP Blood Test- Screens for potential fetal abnormalities such as neural tube defects and chromosomal abnormalities during pregnancy.
Comprehensive Metabolic Panel (CMP-14) with eGFR Blood Test - Commonly used to evaluate nutrient levels, liver, and kidney function.
